A
Aisling Capital Management LP
Private Equity
Aisling Capital Management LP is a Private Equity based in New York, NY led by Andrew Newman Schiff, managing $456.4M across 14 long positions as of Q3 2025 with 81% Healthcare concentration, 99% concentrated in top 10 holdings, and 69% allocation to BBIO.
PresidentAndrew Newman Schiff
- Portfolio Value
- $456.4M
- Positions
- 14
- Top Holding
- BBIO at 69.29%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in Aisling Capital Management LP's portfolio (99.4% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $316.3M | 69.29% | +$1.1M Bought | 3.19% 6.1M shares | |
Unknown Unknown | $65.7M | 14.39% | — | — 615.4K shares | |
Biotechnology Healthcare | $20.3M | 4.44% | — | 1.53% 1.3M shares | |
Biotechnology Healthcare | $11.0M | 2.40% | +$1.6M Bought | 0.86% 3.0M shares | |
Biotechnology Healthcare | $10.9M | 2.39% | — | 2.38% 1.5M shares | |
Unknown Unknown | $9.0M | 1.97% | — | 1.04% 568.9K shares | |
Unknown Unknown | $6.9M | 1.50% | — | — 1.2M shares | |
Unknown Unknown | $6.5M | 1.43% | +$6.5M New | 0.71% 564.6K shares | |
Biotechnology Healthcare | $4.1M | 0.91% | — | 3.44% 2.0M shares | |
Biotechnology Healthcare | $2.9M | 0.63% | +$2.9M New | 0.08% 77.0K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in Aisling Capital Management LP's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
New | |
New | |
+16.52% | |
+0.35% |
Decreased Positions
| Position | Shares Δ |
|---|---|
Sold |
Analytics
Portfolio insights and performance metrics for Aisling Capital Management LP
GthenA